Hst Global, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 19, 2019 at 08:49 pm
Share
HST Global, Inc. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced operating loss was USD 55,008 compared to USD 34,638 a year ago. Net income was USD 540,992 compared to net loss of USD 43,575 a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to USD 0 a year ago. For the nine months, operating loss was USD 126,074 compared to USD 107,970 a year ago. Net income was USD 452,052 compared to net loss of USD 134,781 a year ago. Basic earnings per share from continuing operations was USD 0.01 compared to USD 0 a year ago.
HST Global, Inc. is an integrated health and wellness biotechnology company. The Company is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The Company intends to acquire innovative products for the treatment of life-threatening diseases. The Company primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The Company has not generated any revenue.
HST GLOBAL, INC. 
